Equity Details
Price & Market Data
Price: $0.13
Daily Change: -$0.01 / 7.69%
Daily Range: $0.13 - $0.13
Market Cap: $163,509,536
Daily Volume: 600
Performance Metrics
1 Week: 7.69%
1 Month: 600.0%
3 Months: 40.00%
6 Months: 75.00%
1 Year: 366.7%
YTD: 180.0%
About Bonus BioGroup Ltd. (BBIXF)
Get quick and reliable data for Bonus BioGroup Ltd. (BBIXF). Price: 0.13, daily change: -$0.01 / 7.69%. Market cap: 163,509,536. Performance across all periods for informed decisions.
Company Details
Employees: 42
Sector: Health technology
Industry: Medical specialties
Country: Israel
Details
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is in phase III clinical trial, as well as in preclinical stage for the treatment of other inflammations and tissue damage, including chronic kidney diseases, osteoarthritis, and cytokine release syndrome. The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was incorporated in 1981 and is headquartered in Haifa, Israel.